HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Policy

Blurring the lines of healthcare AI

If you asked me a year ago to break down the different areas of healthcare AI we’re covering, it might’ve looked like scribes, clinical decision support and a whole lot of administrative use cases, like ...

By Endpoints News · Apr 16, 2026 · via Endpoints News
Blurring the lines of healthcare AI

Image: Endpoints News

Tags
policyformat:headlineheadlineEndpoints News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
Roivant’s CEO thinks China is a ‘red herring’
PolicyFierceBiotech ↗
Roivant’s CEO thinks China is a ‘red herring’
China’s biotech rise has been a persistent concern for federal health leaders, Congress, and many biopharma ex…
Apr 18, 2026
AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
PolicyFierceBiotech ↗
AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump adm…
Apr 18, 2026
Trump Administration Again Blocks UNFPA Funding Under Kemp-Kasten
PolicyBriefing
Trump Administration Again Blocks UNFPA Funding Under Kemp-Kasten
Using the Kemp-Kasten amendment, the administration withheld $32.5 million in FY2025 UNFPA support and is expe…
Apr 17, 2026